TRLV Trulieve Cannabis Corp.

Partial data

AMEX · US · Healthcare · Drug Manufacturers - Specialty & Generic · trulieve.com

11.07USD-4.98%Mkt Cap: 2.21B $P/E: —17d ago

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through hom…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap2.21B USD

Enterprise Value2.38B USD

Revenue (TTM)1.14B USD

Gross Profit711.17M USD

Net Income (TTM)-116.38M USD

Revenue/Share5.93 USD

Last Price11.07 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees5.0K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)19.89

PEG—

EV/EBITDA7.92

EV/Revenue2.09

P/S1.87

P/B1.82

EPS (TTM)-2.44

EPS (Forward)0.56

52W Range

4.61674% of range13.28

52W High13.28 USD

52W Low4.616 USD

Profitability

Gross Margin60.21%

Oper. Margin12.84%

EBITDA Margin26.43%

Profit Margin-9.85%

ROE-10.02%

ROA-4.32%

Growth

Revenue Growth-10.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF272.82M USD

CapEx (TTM)60.51M USD

FCF Margin20.37%

FCF Yield10.48%

Net Debt252.45M USD

Net Debt/EBITDA0.84

Balance Sheet

Debt/Equity0.49

Current Ratio5.94

Quick Ratio3.71

Book Value/Sh6.07 USD

Cash/Share1.69 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.1 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)18.18 USD

Upside (mean)+64.2%

Target Range15.00 USD – 21.00 USD

15.00+64.2% to mean21.00

# Analysts7

Ownership

Shares Out.170.16M

Float167.89M

Insiders1.34%

Institutions21.40%

Short Interest

Short Ratio1.4d

Short % Float0.87%

Short % Out.0.75%

Shares Short1.44M

Short (prev mo.)1.32M

Technical

SMA 509.978 (+10.9%)

SMA 2008.371 (+32.2%)

Beta1.76

S&P 52W Chg14.29%

Avg Vol (30d)1.67M

Avg Vol (10d)2.85M

Technical Indicators

RSI (14)53.1

MACD0.5444

MACD Signal0.6557

MACD Hist.-0.1113

BB Upper12.97 USD

BB Middle11.24 USD

BB Lower9.518 USD

BB Width30.67%

ATR (14)0.7552 USD

Vol Ratio (20d)0.78x